CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- 4 Planned sale SVP, Finance & Corp Controller sold 3,000 shares at $9.18 ($27,548)
- 4 Planned sale CCO sold 10,500 shares at $9.19 ($96,500)
- 4 Planned sale SVP, Finance & Corp Controller sold 1,750 shares at $8.82 ($15,442)
- 4 Planned sale Chief Legal & Compliance sold 4,080 shares at $8.83 ($36,010)
- 4 Planned sale Chief Medical Officer sold 4,533 shares at $8.83 ($40,036)
- 4 Planned sale CCO sold 3,375 shares at $8.83 ($29,800)
- 4 Planned sale President and CEO sold 91,000 shares at $9.38 ($853,425)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Former CFO & Treasurer gave up 48,513 shares (to pay taxes)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Executive or director change · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 3 of 44 · 870 filings